Repair of large segmental bone defects: BMP-2 gene activated muscle grafts vs. autologous bone grafting

Clicks: 302
ID: 270369
2013
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Popular

Ranked #15 of 128 articles by views in bmc biotechnology

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 128 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Common cell based strategies for the treatment of osseous defects require the isolation and expansion of autologous cells. Since this makes such approaches time-consuming and expensive, we developed a novel expedited technology creating gene activated muscle grafts. We have previously shown that large segmental bone defects in rats can be regenerated by implantation of muscle tissue fragments activated by BMP-2 gene transfer.
Reference Key
müller2013bmcrepair Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Oliver B Betz,Volker M Betz,Christian Schröder,Rainer Penzkofer,Michael Göttlinger,Susanne Mayer-Wagner,Peter Augat,Volkmar Jansson,Peter E Müller;Oliver B Betz;Volker M Betz;Christian Schröder;Rainer Penzkofer;Michael Göttlinger;Susanne Mayer-Wagner;Peter Augat;Volkmar Jansson;Peter E Müller;
Journal bmc biotechnology
Year 2013
DOI
10.1186/1472-6750-13-65
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.